Exploring GSTP1 as a Potential Protective Target in Sepsis: Insights from Proteome-Wide Mendelian Randomization and Multi-Omics Studies - Takeaways - MDSpire

Exploring GSTP1 as a Potential Protective Target in Sepsis: Insights from Proteome-Wide Mendelian Randomization and Multi-Omics Studies

  • By

  • Peng Peng

  • Xiudao Song

  • Jia Dan

  • Xuejiao Zhu

  • Xiaoxiao Zhang

  • Dan Xu

  • Hairui Liu

  • February 2, 2026

  • 0 min

Share

  • 1

    Sepsis affects approximately 49 million individuals globally, with mortality rates ranging from 25% to 55%, highlighting a significant health challenge.

  • 2

    Current sepsis treatments, including antibiotics and organ support, have not significantly reduced mortality, emphasizing the need for new therapeutic strategies.

  • 3

    Mendelian randomization (MR) offers a method to establish causal relationships between genetic variants and sepsis risk, reducing confounding factors.

  • 4

    The study integrated cis-pQTL GWAS data with multi-omics approaches to identify potential therapeutic targets and understand sepsis pathogenesis.

  • 5

    Findings from this research could lead to novel diagnostic strategies and targeted therapies by elucidating the molecular pathways involved in sepsis.

Original Source(s)

Exploring GSTP1 as a Potential Protective Target in Sepsis: Insights from Proteome-Wide Mendelian Randomization and Multi-Omics Studies

  • by Peng Peng, Xiudao Song, Jia Dan, Xuejiao Zhu, Xiaoxiao Zhang, Dan Xu, Hairui Liu

  • February 2, 2026

Related Content

Creation and temporal assessment of the SCRAPS scoring system for forecasting adverse outcomes in patients with gram-negative sepsis requiring early admission to intensive care or high dependency units

Relationship of Pulse Pressure Measurements with Mortality Outcomes in Septic Shock Patients: A Retrospective Cohort Analysis

Neutrophil-to-lymphocyte ratio as a practical alternative to mHLA-DR measurement in delayed sepsis-induced immunosuppression